Well said @Wyman Wells ...it seems to be a familiar story at this time of year.
Here's hoping the trial does work out tho. Innate Immuno (biotech) posted results today of a drug-trial that does not work.
I'll leave you to see what a share price does when a drug-trial doesn't work out.
Tis not pretty. ;-)
But as I said, it is speculative. So you either win or lose. There is no constant income slowly building market share. At least not until you get a win.
As I always say with this one...good luck...
Ann: Cynata Therapeutics GvHD Clinical Trial & Corporate Progress, page-37
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $43.36M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $8.739K | 34.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19841 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 15.44pm 18/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |